Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fnu Sagar"'
Autor:
Ahmad Iftikhar, Hamza Hassan, Mayar Al Mohajer, Rabih O. Darouiche, Aneela Majeed, Azka Latif, Fnu Sagar
Publikováno v:
Expert Review of Medical Devices. 16:809-820
Introduction: Catheter-associated urinary tract infection (CAUTI) is one of the most common nosocomial infections in hospitals, accounting for 36% of all health care-associated infections. Areas covered: We aimed to address the potential impact of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::589eebf7b2b41c957df723e54a2f5037
https://doi.org/10.1080/17434440.2019.1661774
https://doi.org/10.1080/17434440.2019.1661774
Autor:
Zeeshan Ali, Sreejata Raychaudhuri, Midhat Lakhani, Adeela Mushtaq, Ahmad Kamal, Syeda Fatima Hassan, Fnu Sagar, Muhammad Abu Zar, Hamza Hassan, Faryal Razzaq, Umar Zahid, Ahmad Iftikhar, Ahmad Safdar, Faiz Anwer
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:447-461
Introduction Pomalidomide (Pom) has demonstrated synergistic antiproliferative activity in combination regimens as a result of its distinct anticancer, antiangiogenic, and immunomodulatory effects. This review aimed to compare outcome measures of dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76a7e6386ea81b77560212624a8b24b3
https://doi.org/10.1016/j.clml.2019.04.003
https://doi.org/10.1016/j.clml.2019.04.003
Autor:
Zeeshan Baig, Seren Durer, Muhammad Junaid Tariq, Muhammad Usman, Ali Younas Khan, Muhammad Asad Fraz, Nadia Carenina Nunes Cavalcante Parr, Saad Ullah Malik, Atlantis Dawn Russ, Ceren Durer, Faiz Anwer, Warda Faridi, Fnu Sagar, Awais Ijaz, Ali McBride, Zeeshan Ali
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:94-99
Investigators are using checkpoint inhibitors (CPIs) to treat aggressive hematologic malignancies in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and in some patients with relapsed disease after allo-HSCT. CTLA-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c26247d7e5e7c8c54edf58fa00bab36f
https://doi.org/10.1016/j.bbmt.2018.08.028
https://doi.org/10.1016/j.bbmt.2018.08.028
Extrapyramidal Symptoms with Administration of Lenalidomide Maintenance Therapy for Multiple Myeloma
Autor:
Supranee Soontornprueksa, Mohammad A Fraz, Ali Younas Khan, Fnu Sagar, Awais Ijaz, Saad Ullah Malik, Faiz Anwer, Muhammad Usman, Pavan Tenneti
Publikováno v:
Cureus
Lenalidomide is commonly used as induction or maintenance therapy in multiple myeloma. We report a case of 71-year-old female presenting with tardive dyskinesia-like symptoms one month after starting her lenalidomide maintenance therapy after high-do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96dbbbd32493bd703e33119e224c638f
https://doi.org/10.7759/cureus.3349
https://doi.org/10.7759/cureus.3349
Publikováno v:
Cureus
We report a case of a patient with relapsed Ewing’s sarcoma (ES). After receiving conventional chemotherapy (CC) and noticing chemosensitivity of the disease, we proceeded to give the patient two separate cycles of HDCT consisting of a melphalan/bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2679dff2d5a3db5d857209d339c2585d
https://doi.org/10.7759/cureus.2581
https://doi.org/10.7759/cureus.2581
Publikováno v:
Cureus
Immunocompromised patients undergoing chemotherapy for hematologic malignancy and hematopoietic stem cell transplant (HSCT) recipients are at increased risk of Clostridium difficile (C. difficile) infection (CDI). The recurrence of infection and its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9121bdf841c2e64f6f86db8fb50178f6
https://doi.org/10.7759/cureus.2413
https://doi.org/10.7759/cureus.2413
Autor:
Fnu Sagar, Mayar Al Mohajer, Muhammad Usman, Muhammad Asad Fraz, Umar Zahid, Ahmad Iftikhar, Adeela Mushtaq, Aneela Majeed
Publikováno v:
Open Forum Infectious Diseases
Background Diabetic foot ulcers (DFUs) cause significant morbidity and put great economic burden on patient and healthcare facilities. Infection is the main driving force behind admissions related to DFU. Culture of soft tissue or bone is invaluable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceacceae58ba8a127ed7e8269683023f
http://europepmc.org/articles/PMC6254127
http://europepmc.org/articles/PMC6254127
Autor:
Muhammad Usman, Chaudhry Saad Sohail, Faiz Anwer, Seren Durer, Muhammad Junaid Tariq, Malik Qistas Ahmad, Ceren Durer, Ali Younas Khan, Muhammad Jahanzeb Khalil, Muhammad Asad Fraz, Zunairah Shah, Shehroz Aslam, Awais Ijaz, Fnu Sagar
Publikováno v:
Blood. 132:5722-5722
Introduction: Allogenic stem cell transplantation (allo-SCT) is a potentially curative option for hematological malignancies. Checkpoint inhibitors (CPI) have been successful in achieving remission for patients that relapse after allo-SCT. CPI can he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39b3cc58de08a4e8df450a51e154119b
https://doi.org/10.1182/blood-2018-99-110006
https://doi.org/10.1182/blood-2018-99-110006
Autor:
Muhammad Abu Zar, Faryal Razzaq, Faiz Anwer, Mohammad Bilal Chaudhary, Saad Ullah Malik, Adeela Mushtaq, Umar Zahid, Ahmad Iftikhar, Ahmad Kamal, Midhat Lakhani, Syeda Fatima Hassan, Ahmad Safdar, Fnu Sagar, Hamza Hassan, Zeeshan Ali, Mohamed Mokhtar Bakr
Publikováno v:
Blood. 132:2022-2022
Introduction Bortezomib, a proteasome inhibitor and lenalidomide (Len), an immunomodulatory drug are the backbone of established treatment regimens for newly diagnosed MM. Patients with dual-refractory (refractory to both bortezomib and lenalidomide)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c5771c19628ddca79717efa91f5f0fb
https://doi.org/10.1182/blood-2018-99-111439
https://doi.org/10.1182/blood-2018-99-111439
Autor:
Muhammad Jahanzeb Khalil, Muhammad Asad Fraz, Muhammad Junaid Tariq, Warda Faridi, Faiz Anwer, Abid Hussain, Saad Ullah Malik, Malik Qistas Ahmad, Ceren Durer, Midhat Lakhani, Awais Ijaz, Amna Khalid, Seren Durer, Muhammad Usman, Fnu Sagar
Publikováno v:
Blood. 132:3239-3239
Introduction: Survival of patients with multiple myeloma (MM) has improved over the last decade, mainly due to advent of newer drugs, three drug based induction, high dose chemotherapy consolidation and routine use of maintenance therapy for eligible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f395c081a7ddbc4344e2ebd037f1f8b
https://doi.org/10.1182/blood-2018-99-111930
https://doi.org/10.1182/blood-2018-99-111930